PLP1 and Pelizeaus-Merzbacher spectrum disorder: Notably, a recent study using PLP1-targeting ASO has demonstrated a prominent therapeutic effect in the PMD patient iPSC-derived oligodendrocytes as well as the PMD-mimic Plp1 mutant Jimpy mice [293].